“…The main indications elaborated have been delineated in published papers. Aside from bone marrow scintigraphy which was not investigated in the study under discussion here, the indications were consistent with the main areas studied in the present clinical trial: inflammatory changes involving joints, joint prostheses and the (peripheral) skeleton (14,21,24,48,57,62,63), abdominal inflammatory disorders, particularly involving the intestine (11,38,46,65), endocarditis (3,45), and febrile episodes of unknown aetiology (5,7,25,42).…”